Market Place
Sourcing Support
Viatris Gets Approval for First US Generic Iron Sucrose Injection
11 Aug 2025 //
PR NEWSWIRE
Viatris Clears Legal Hurdle on Road to Potential Wegovy Generic
24 Jul 2025 //
FIERCE PHARMA
J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
09 Jul 2025 //
REUTERS
Viatris Reports Q1 2025 Results, Reaffirms 2025 Outlook
08 May 2025 //
PR NEWSWIRE
Viatris Announces Quarterly Dividend
07 May 2025 //
PR NEWSWIRE
Novo settles with Mylan over potential Ozempic generic
07 Oct 2024 //
FIERCE PHARMA
Gilead inks licensing deals to boost lenacapivir access
02 Oct 2024 //
FIERCE PHARMA
Viagra-maker Viatris beats Q2 estimates on branded and generic drug demand
08 Aug 2024 //
REUTERS
Department of Justice No Longer Considers Mylan Subject Of Antitrust
02 Jul 2024 //
PR NEWSWIRE
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
02 Apr 2024 //
REUTERS
Viatris core profit beats on generic drugs strength
07 Nov 2023 //
REUTERS
Viatris Announces Launch of Breyna™ Inhalation Aerosol
01 Aug 2023 //
PR NEWSWIRE
Viatris leans in on brand drug portfolio for future growth
08 May 2023 //
ENDPTS
GSK licenses companies to make cheap copies of HIV prevention drug
30 Mar 2023 //
REUTERS
Novartis files another Entresto patent suit to fight generics
27 Oct 2022 //
FIERCEPHARMA
Mylan Loses Tribunal Challenge to Merck Diabetes Treatment Patent
11 May 2021 //
BLOOMBERGLAW
Viatris & Kindeva Announce First ANDA, Generic of Symbicort® Inhalation Aerosol
08 Mar 2021 //
PRNEWSWIRE
Mylan prices its generic remdesivir in India at $64 per 100 mg vial
06 Jul 2020 //
REUTERS
Mylan gets DGCI nod, to launch generic remdesivir at Rs 4,800 per vial
06 Jul 2020 //
BUSINESS-STANDARD
Attorneys general bring another ‘collusion’ case against generic makers
12 Jun 2020 //
ENDPTS
States file 3rd generics price-fixing suit against 26 firms
11 Jun 2020 //
FIERCEPHARMA
Pressure on generic drugmakers increases with new price fixing lawsuit
10 Jun 2020 //
BIOPHARMADIVE
Mylan Gets OK To Sell Generic Insomnia Drug During IP Fight
04 Jun 2020 //
LAW360
Mylan offers concessions to address EU concerns about Pfizer deal
01 Apr 2020 //
REUTERS
EpiPen Buyers Tear Into Mylan, Pfizer Bid For Cert. Review
25 Mar 2020 //
LAW360
Say hello to Viatris: Pfizer`s Upjohn, Mylan merger gets a name
13 Nov 2019 //
FIERCE PHARMA
UPDATE 3-Mylan shares slide after warning of hit to revenue
06 Nov 2019 //
CNBC
Think Mylan`s done with M&A after its Pfizer deal? Think again
05 Nov 2019 //
FIERCE PHARMA
Product Hopping: E&C Hearing Addresses Restrictions to Generic Competition
19 Sep 2019 //
RAPS
J&J finds competitive edge with latest Erleada approval
19 Sep 2019 //
BIOPHARMADIVE
Mylan launches generic Faslodex inj in US market to treat advanced breast cancer
19 Sep 2019 //
PHARMABIZ
Biocon And Mylan Get CRL From FDA For Lantus Rival
05 Sep 2019 //
PHARMAINTELLIGENCE
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
03 Sep 2019 //
CNBC
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
23 Aug 2019 //
BIOSPACE
Sanofi patent case win holds off generic rivals for key cancer drug
16 Aug 2019 //
PMLIVE
300 Drugs Now Under Investigation in “Generic Drug Cartel”
31 Jul 2019 //
POLICYMED
With its generic spin-off cash, will Pfizer step up its buying game?
31 Jul 2019 //
FIERCE PHARMA
New respiratory drugs, Shingrix help GSK weather Advair generics
25 Jul 2019 //
FIERCE PHARMA
Lawmakers urge DoJ to get moving on generic price fixing probe
17 Jun 2019 //
FIERCE PHARMA
Generics `cartel` reaped billions from price fixing: lawsuit
14 May 2019 //
FIERCE PHARMA
Mylan Expands Oncology Portfolio with Launch of Generic Tarceva® Tablets
11 May 2019 //
PR NEWSWIRE
Generic Advair hits GSK revenues hard
01 May 2019 //
BIOPHARMADIVE
Auryxia (Ferric Citrate) : Keryx Biopharma vs. Mylan Pharma
18 Mar 2019 //
PATENT LITIGATION
Mylan`s Advair generic pressures GSK with strong launch
08 Mar 2019 //
BIOPHARMADIVE
Suboxone competition ramps up as Indivior and Mylan launch generics
25 Feb 2019 //
IN-PHARMATECHNOLOGIST
Mylan Launches Generic Suboxone® Sublingual Film to Treat Opioid Dependence
22 Feb 2019 //
PR NEWSWIRE
Janumet (metformin hydrochloride; sitagliptin phosphate) : Merck vs. Mylan
14 Feb 2019 //
PATENT LITIGATION
Mylan`s generic Advair discount not as big as it looks: analysts
14 Feb 2019 //
FIERCE PHARMA
More Pain for Warner-Lambert and Their Pregabalin Patent
07 Feb 2019 //
PATENT DOCS
Hundreds of EpiPen users complained about problems with the lifesaving device
01 Feb 2019 //
BUSINESS INSIDER
Teva`s generic EpiPen launch stalls months after approval
31 Jan 2019 //
REUTERS
Stribild (elvitegravir) Japan Tobacco v. Mylan Pharma
29 Jan 2019 //
PATENT LITIGATION
Sandoz launches EpiPen rival at $250 per two-pack
18 Jan 2019 //
BIOPHARMA DIVE
Mylan snaps up HIV-focused South African facility from Ascendis for $9.4M
10 Jan 2019 //
FIERCE PHARMA
Ironwood & Allergan Settlement with Mylan Resolving LINZESS® (linaclotide)
03 Jan 2019 //
BUSINESSWIRE
Sanofi`s Formulation Patents on Lantus Invalidated by USPTO, Announces Mylan
22 Dec 2018 //
PR NEWSWIRE
Linzess (linaclotide) : Allergan, Ironwood Pharmaceuticals vs. Mylan Pharms
20 Dec 2018 //
PATENT LITIGATION
Cialis (tadalafil) : Eli Lilly vs. Qilu Pharm Co., Ltd.
20 Dec 2018 //
PATENT LITIGATION
Launch of Generic Lialda DR Tablets Expands Mylan`s GE Offering
18 Dec 2018 //
PR NEWSWIRE
Mylan Adds First Generic for Canasa® Rectal Suppository to Growing GE portfolio
18 Dec 2018 //
PR NEWSWIRE
